Cargando…
The reversal of antineoplastic drug resistance in cancer cells by β-elemene
Multidrug resistance (MDR), defined as the resistance of cancer cells to compounds with diverse structures and mechanisms of actions, significantly limits the efficacy of antitumor drugs. A major mechanism that mediates MDR in cancer is the overexpression of adenosine triphosphate (ATP)-binding cass...
Autores principales: | Zhang, Guan-Nan, Ashby, Charles R., Zhang, Yun-Kai, Chen, Zhe-Sheng, Guo, Huiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593349/ https://www.ncbi.nlm.nih.gov/pubmed/26370907 http://dx.doi.org/10.1186/s40880-015-0048-0 |
Ejemplares similares
-
The Role of E3 Ubiquitin Ligase Cbl Proteins in β-Elemene Reversing Multi-Drug Resistance of Human Gastric Adenocarcinoma Cells
por: Zhang, Ye, et al.
Publicado: (2013) -
Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
por: Zhai, Bingtao, et al.
Publicado: (2018) -
Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review
por: Tan, Tiantian, et al.
Publicado: (2021) -
Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990) -
β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)